menu

CME: How Improved Hepatitis B Vaccination Coverage Can Protect At-Risk Adults

Be part of the knowledge.
Register

ReachMD is even better when
you join the community!
Registration is free and easy.

Register Now

How Improved Hepatitis B Vaccination Coverage Can Protect At-Risk Adults

How Improved Hepatitis B Vaccination Coverage Can Protect At-Risk Adults
RestartResume
Hepatitis B vaccines are safe and effective, yet only about 25% of US adults are vaccinated against hepatitis B virus, HBV, as recommended.

Available credits: 0.50

Time to complete: 30 Minutes

Released:

Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    Expert Interview is a 30-minute activity that offers healthcare professionals insights into the experiences of medical experts. During this concise, easy to digest thirty-minute segment, National Foundation for Infectious Diseases (NFID) Medical Director William Schaffner, MD, conducts an interview with key thought leader Arthur L. Reingold, MD on hepatitis B and the importance of vaccination in US adults. This session highlights the unique experience and knowledge of the faculty, broadening listeners’ perspectives about the burden of hepatitis B virus infections in US adults and the importance of vaccination to prevent new infection and interrupt further transmission of the virus.

  • Learning Objectives

    At the conclusion of this activity, participants will be able to:

    • Discuss the epidemiology of acute and chronic hepatitis B virus (HBV) infection in the US
    • Summarize Centers for Disease Control and Prevention (CDC) immunization recommendations for adult populations at risk for HBV infection
    • Discuss data on hepatitis B vaccine safety and efficacy
    • Assess interventions to increase adult hepatitis B vaccination rates for implementation in practice
  • Target Audience

    This program is intended for physicians and related healthcare professionals.

  • Disclosure of Conflicts of Interest

    It is the policy of the National Foundation for Infectious Diseases (NFID) to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. All individuals in a position to control the content of the activity have disclosed relevant financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and/or with any commercial supporters of the activity. Disclosure information is reviewed in advance to manage and resolve any real or perceived conflict of interest that may affect the balance and scientific integrity of an educational presentation.

    • Marla Dalton (NFID staff, content reviewer) owns stock, stock options, patent, or other intellectual property from Merck & Co., Inc.
    • William Schaffner (NFID medical director, host, and content reviewer) served as an advisor or consultant for Dynavax Technologies Corporation, Merck & Co., Inc., Pfizer Inc., Seqirus, Shionogi Inc., and SutroVax.

    All other individuals in a position to control the content of this activity have no relevant financial relationships to disclose.

  • Accreditation and Credit Designation Statements

    Accreditation Statement
    The National Foundation for Infectious Diseases (NFID) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Credit Designation
    The National Foundation for Infectious Diseases designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider(s)/Educational Partner(s)

  • Commercial Support

    This program is supported by an unrestricted educational grant from Dynavax Technologies Corporation. NFID policies restrict funders from controlling program content.

  • Terms of Use

    This activity is designed to be completed within the time designated on the activity home page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn AMA PRA Category 1 Credit™, participants must complete the activity online during the valid credit period noted and receive a minimum passing score of 80% on the post-test.

    Follow these steps to earn CME credit:
    1. Read the learning objectives, target audience, and disclosure of conflicts of interest.
    2. Complete the online educational activity.
    3. Complete the online post-test with a minimum passing score of 80% and the online evaluation.

  • System Requirements

    Our site requires a computer, tablet or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/cable). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Internet Explorer, Microsoft Edge, Chrome, Firefox or Safari. Users accustomed to IE8, IE9 IE10 are advised to update their browsers for the best experience.

Facebook Comments

You must be in to display playlists.

Get a Dose of ReachMD in Your Inbox
and Practice Smarter Medicine

Stay current with the best in medical education.